Cargando…

Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds

Currently, it is estimated that 1–2 million people worldwide are infected with HIV-2, accounting for 3–5% of the global burden of HIV. The course of HIV-2 infection is longer compared to HIV-1 infection, but without effective antiretroviral therapy (ART), a substantial proportion of infected patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moranguinho, Inês, Taveira, Nuno, Bártolo, Inês
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053740/ https://www.ncbi.nlm.nih.gov/pubmed/36982978 http://dx.doi.org/10.3390/ijms24065905

Ejemplares similares

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals
por: Martin, Francisco, et al.
Publicado: (2022)

Block-And-Lock: New Horizons for a Cure for HIV-1
por: Moranguinho, Ines, et al.
Publicado: (2020)

HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola
por: Bártolo, Inês, et al.
Publicado: (2014)

High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients
por: Bártolo, Inês, et al.
Publicado: (2022)

Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection
por: Barroso, Helena, et al.
Publicado: (2011)

An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates
por: Taveira, Nuno, et al.
Publicado: (2023)

Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique
por: Palladino, Claudia, et al.
Publicado: (2013)

Origin and Epidemiological History of HIV-1 CRF14_BG
por: Bártolo, Inês, et al.
Publicado: (2011)

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal
por: Palladino, Claudia, et al.
Publicado: (2018)

Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation
por: Romero-Severson, Ethan O., et al.
Publicado: (2017)

Unveiling a family of spiro-β-lactams with anti-HIV and antiplasmodial activity via phosphine-catalyzed [3+2] annulation of 6-alkylidene-penicillanates and allenoates
por: Alves, Américo J. S., et al.
Publicado: (2022)

Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil
por: Santos-Pereira, Ana, et al.
Publicado: (2021)

HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients
por: Xing, Hui, et al.
Publicado: (2013)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies
por: Calado, Rita, et al.
Publicado: (2020)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
por: Iyidogan, Pinar, et al.
Publicado: (2014)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research
por: Eaton, Ellen F., et al.
Publicado: (2016)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children
por: Soto-Ramirez, Luis E., et al.
Publicado: (2010)

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
por: Xing, Hui, et al.
Publicado: (2013)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

HIV drug resistance and antiretroviral therapy programs in Henan, China
por: Liu, Zhi-Bin, et al.
Publicado: (2020)

HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
por: Geretti, Anna Maria, et al.
Publicado: (2022)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
por: Alghamdi, Saad, et al.
Publicado: (2020)

Detection of low frequency drug resistant mutations in antiretroviral-treated HIV-1C infections
por: Okatch, Harriet, et al.
Publicado: (2006)

Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya
por: Steegen, Kim, et al.
Publicado: (2009)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
por: Alteri, Claudia, et al.
Publicado: (2009)

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran
por: Memarnejadian, Arash, et al.
Publicado: (2015)

Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand
por: Sungkanuparph, Somnuek, et al.
Publicado: (2012)

Determinants of Highly Active Antiretroviral Therapy Duration in HIV-1-Infected Children and Adolescents in Madrid, Spain, from 1996 to 2012
por: Palladino, Claudia, et al.
Publicado: (2014)

HIV drug resistance among adults initiating antiretroviral therapy in Uganda
por: Watera, Christine, et al.
Publicado: (2021)

HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania
por: Vairo, Francesco, et al.
Publicado: (2013)

Palliative care for HIV in the era of antiretroviral therapy availability: perspectives of nurses in Lesotho
por: Kell, Megan E, et al.
Publicado: (2009)

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
por: Stelitano, Giovanni, et al.
Publicado: (2020)

Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)
por: Srasuebkul, Preeyaporn, et al.
Publicado: (2007)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Emergence of HIV-1 drug resistance in antiretroviral therapy experienced perinatally infected children in South India
por: Neogi, Ujjwal, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0cpni0gp7q5frhmmpogsbbmlit